New patent for Viiv Hlthcare drug APRETUDE

February 11, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for APRETUDE Apretude is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. The generic ingredient in…

The post New patent for Viiv Hlthcare drug APRETUDE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.